Development of Berberine-Loaded Nanoparticles for Astrocytoma Cells Administration and Photodynamic Therapy Stimulation

Berberine (BBR) is known for its antitumor activity and photosensitizer properties in anti-cancer photodynamic therapy (PDT), and it has previously been favorably assayed against glioblastoma multiforme (GBM)-derived cells. In this work, two BBR hydrophobic salts, dodecyl sulfate (S) and laurate (L), have been encapsulated in PLGA-based nanoparticles (NPs), chitosan-coated by the addition of chitosan oleate in the preparation. NPs were also further functionalized with folic acid. All the BBR-loaded NPs were efficiently internalized into T98G GBM established cells, and internalization increased in the presence of folic acid. However, the highest mitochondrial co-localization percentages were obtained with BBR-S NPs without folic acid content. In the T98G cells, BBR-S NPs appeared to be the most efficient in inducing cytotoxicity events and were therefore selected to assess the effect of photodynamic stimulation (PDT). As a result, PDT potentiated the viability reduction for the BBR-S NPs at all the studied concentrations, and a roughly 50% reduction of viability was obtained. No significant cytotoxic effect on normal rat primary astrocytes was observed. In GBM cells, a significant increase in early and late apoptotic events was scored by BBR NPs, with a further increase following the PDT scheme. Furthermore, a significantly increased depolarization of mitochondria was highlighted following BBR-S NPs’ internalization and mostly after PDT stimulation, compared to untreated and PDT-only treated cells. In conclusion, these results highlighted the efficacy of the BBR-NPs-based strategy coupled with photoactivation approaches to induce favorable cytotoxic effects in GBM cells.

[1]  M. C. Bonferoni,et al.  Nanoemulsions of Clove Oil Stabilized with Chitosan Oleate—Antioxidant and Wound-Healing Activity , 2023, Antioxidants.

[2]  H. Liu,et al.  Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy , 2022, Frontiers in Immunology.

[3]  K. Hanaoka,et al.  Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors , 2022, World journal of clinical oncology.

[4]  Mohammed A. Alsahli,et al.  Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways , 2022, Molecules.

[5]  X. Wang,et al.  Drug-loaded PEG-PLGA nanoparticles for cancer treatment , 2022, Frontiers in Pharmacology.

[6]  Kaoxiang Sun,et al.  Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration , 2022, Frontiers in Pharmacology.

[7]  M. C. Bonferoni,et al.  Association of Indocyanine Green with Chitosan Oleate Coated PLGA Nanoparticles for Photodynamic Therapy , 2022, Pharmaceutics.

[8]  A. Azzalin,et al.  Enhanced Delivery of Rose Bengal by Amino Acids Starvation and Exosomes Inhibition in Human Astrocytoma Cells to Potentiate Anticancer Photodynamic Therapy Effects , 2022, Cells.

[9]  Zhenning Yan,et al.  Novel berberine-based pharmaceutical salts with fatty acid anions: Synthesis, characterization, physicochemical properties , 2022, Journal of Molecular Liquids.

[10]  B. Bibak,et al.  Anticancer mechanisms of Berberine: a good choice for glioblastoma multiforme therapy. , 2022, Current medicinal chemistry.

[11]  Heng Li,et al.  Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders , 2022, Pharmacological Reports.

[12]  A. Rauf,et al.  Berberine as a Potential Anticancer Agent: A Comprehensive Review , 2021, Molecules.

[13]  A. Azzalin,et al.  Berberine Photo-Activation Potentiates Cytotoxicity in Human Astrocytoma Cells through Apoptosis Induction , 2021, Journal of personalized medicine.

[14]  N. Udupa,et al.  Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells , 2021, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[15]  M. Amela‐Cortes,et al.  From molecules to nanovectors: current state of the art and applications of photosensitizers in photodynamic therapy. , 2021, International journal of pharmaceutics.

[16]  A. Laquérriere,et al.  Diagnosis and Management of Glioblastoma: A Comprehensive Perspective , 2021, Journal of personalized medicine.

[17]  L. Grøndahl,et al.  Chitosan Nanomedicine in Cancer Therapy: Targeted Delivery and Cellular Uptake. , 2021, Macromolecular bioscience.

[18]  J. Mahendra,et al.  Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies , 2021, Phytotherapy research : PTR.

[19]  B. Salehi,et al.  Nanotechnology-Based Strategies for Berberine Delivery System in Cancer Treatment: Pulling Strings to Keep Berberine in Power , 2021, Frontiers in Molecular Biosciences.

[20]  Qingtao Zhang,et al.  Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma , 2020, Journal of applied biomaterials & functional materials.

[21]  M. Mansournia,et al.  The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment. , 2020, International journal of biological macromolecules.

[22]  C. Chesta,et al.  Photodynamic therapy of Glioblastoma cells using doped conjugated polymer nanoparticles: An in vitro comparative study based on redox status. , 2020, Journal of photochemistry and photobiology. B, Biology.

[23]  M. Calmon,et al.  Effect of Berberine Associated with Photodynamic Therapy in Cell Lines. , 2020, Photodiagnosis and photodynamic therapy.

[24]  K. Honke,et al.  Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model. , 2020, Journal of neurosurgery.

[25]  A. Azzalin,et al.  Development of Artificial Plasma Membranes Derived Nanovesicles Suitable for Drugs Encapsulation , 2020, Cells.

[26]  Seyedeh Sara Esnaashari,et al.  Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. , 2020, Life sciences.

[27]  Michael R Hamblin,et al.  Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine. , 2020, Colloids and surfaces. B, Biointerfaces.

[28]  R. Bellazzi,et al.  The Search for Molecular Markers in a Gene-Orphan Case Study of a Pediatric Spinal Cord Pilocytic Astrocytoma , 2020, Cancer Genomics & Proteomics.

[29]  M. Calmon,et al.  Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  Jun Liang,et al.  Angiopep-2 Modified Cationic Lipid-Poly-Lactic-Co-Glycolic Acid Delivery Temozolomide and DNA Repair Inhibitor Dbait to Achieve Synergetic Chemo-Radiotherapy Against Glioma. , 2019, Journal of nanoscience and nanotechnology.

[31]  S. Rossi,et al.  Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol , 2019, Marine drugs.

[32]  Ajazuddin,et al.  Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics , 2019, Pharmaceutical Research.

[33]  B. Amini,et al.  Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems , 2019, Drug development research.

[34]  Wei Pan,et al.  Boosting the photodynamic therapy efficiency with a mitochondria-targeted nanophotosensitizer , 2019, Chinese Chemical Letters.

[35]  S. Khoei,et al.  Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. , 2019, The international journal of biochemistry & cell biology.

[36]  Y. Kuo,et al.  Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)‑poly(ε‑caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid. , 2019, Materials science & engineering. C, Materials for biological applications.

[37]  Haiyan Hu,et al.  Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[38]  H Stepp,et al.  5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas , 2019, Journal of Neuro-Oncology.

[39]  J. Kreuter,et al.  Toxicological study of doxorubicin‐loaded PLGA nanoparticles for the treatment of glioblastoma , 2019, International journal of pharmaceutics.

[40]  S. Mordon,et al.  INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial. , 2018, Neurosurgery.

[41]  R. Srivastava,et al.  Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[42]  F. Kiessling,et al.  PLGA-Based Nanoparticles in Cancer Treatment , 2018, Front. Pharmacol..

[43]  B. Vigani,et al.  Chitosan Oleate Salt as an Amphiphilic Polymer for the Surface Modification of Poly-Lactic-Glycolic Acid (PLGA) Nanoparticles. Preliminary Studies of Mucoadhesion and Cell Interaction Properties , 2018, Marine drugs.

[44]  N. Eivazi,et al.  Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. , 2018, Photodiagnosis and photodynamic therapy.

[45]  B. Malaekeh-Nikouei,et al.  Nano strategies for berberine delivery, a natural alkaloid of Berberis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[46]  A. Bianucci,et al.  Cell-specific pattern of berberine pleiotropic effects on different human cell lines , 2018, Scientific Reports.

[47]  B. Harley,et al.  Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification , 2018, Front. Bioeng. Biotechnol..

[48]  A. A. Abd El-Aty,et al.  Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies. , 2018, Nanomedicine.

[49]  K. Gupta,et al.  Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors , 2018, Drug Delivery and Translational Research.

[50]  Yi Guo,et al.  Rhizoma Coptidis and Berberine as a Natural Drug to Combat Aging and Aging-Related Diseases via Anti-Oxidation and AMPK Activation , 2017, Aging and disease.

[51]  Bijan Kumar Paul,et al.  Differential interaction behaviors of an alkaloid drug berberine with various bile salts. , 2017, Journal of colloid and interface science.

[52]  F. Söylemezoğlu,et al.  Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model. , 2017, Materials science & engineering. C, Materials for biological applications.

[53]  Cem Varan,et al.  Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment , 2017, Beilstein journal of nanotechnology.

[54]  J. Moffat,et al.  Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[55]  Liming Nie,et al.  Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. , 2016, Chemical Society reviews.

[56]  S. Blanc,et al.  A comparative study of nine berberine salts in the solid state: optimization of the photoluminescence and self-association properties through the choice of the anion. , 2016, Physical chemistry chemical physics : PCCP.

[57]  Jia Song,et al.  Development of a novel berberine-mediated mitochondria-targeting nano-platform for drug-resistant cancer therapy. , 2016, Journal of materials chemistry. B.

[58]  G. Bourg-Heckly,et al.  Berberine as a photosensitizing agent for antitumoral photodynamic therapy: Insights into its association to low density lipoproteins. , 2016, International journal of pharmaceutics.

[59]  Xin Zhang,et al.  Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway , 2016, Oncotarget.

[60]  M. Weller,et al.  Therapeutic options in recurrent glioblastoma--An update. , 2016, Critical reviews in oncology/hematology.

[61]  J. Akimoto Photodynamic Therapy for Malignant Brain Tumors , 2016, Neurologia medico-chirurgica.

[62]  P. Kesharwani,et al.  PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery. , 2016, Critical reviews in therapeutic drug carrier systems.

[63]  Baochang Cai,et al.  Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery. , 2015, Biomaterials.

[64]  Xiongbin Lu,et al.  Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells. , 2015, ACS nano.

[65]  Na Li,et al.  Berberine exhibits antitumor effects in human ovarian cancer cells. , 2015, Anti-cancer agents in medicinal chemistry.

[66]  N. Chung,et al.  Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[67]  A. Scovassi,et al.  Berberine, an Epiphany Against Cancer , 2014, Molecules.

[68]  Abolfazl Akbarzadeh,et al.  PLGA-based nanoparticles as cancer drug delivery systems. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[69]  Liang Zhao,et al.  Folic Acid-Chitosan Conjugated Nanoparticles for Improving Tumor-Targeted Drug Delivery , 2013, BioMed research international.

[70]  Hiroshi Iseki,et al.  Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. , 2013, Journal of neurosurgery.

[71]  Daniel J. Sargent,et al.  Drug rechallenge and treatment beyond progression—implications for drug resistance , 2013, Nature Reviews Clinical Oncology.

[72]  C. Miracco,et al.  microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells , 2013, Cancer biology & therapy.

[73]  G. Reifenberger,et al.  Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. , 2012, The Lancet. Oncology.

[74]  Yitao Wang,et al.  Berberine hydrochloride: anticancer activity and nanoparticulate delivery system , 2011, International journal of nanomedicine.

[75]  Michael R Hamblin,et al.  Cell Death Pathways in Photodynamic Therapy of Cancer , 2011, Cancers.

[76]  T. Hamamoto,et al.  Nanoparticles electrostatically coated with folic acid for effective gene therapy. , 2011, Molecular pharmaceutics.

[77]  V. Bagnato,et al.  Apoptosis in glioma cells treated with PDT. , 2011, Photomedicine and laser surgery.

[78]  P. Lyu,et al.  Characterization of photodynamic therapy responses elicited in A431 cells containing intracellular organelle‐localized photofrin , 2010, Journal of cellular biochemistry.

[79]  S. Majumdar,et al.  Physicochemical Characterization of Berberine Chloride: A Perspective in the Development of a Solution Dosage Form for Oral Delivery , 2010, AAPS PharmSciTech.

[80]  Y. Di,et al.  Thermal behavior and thermodynamic properties of berberine hydrochloride , 2013, Journal of Thermal Analysis and Calorimetry.

[81]  T. Hsia,et al.  Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. , 2009, Anticancer research.

[82]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[83]  S. Katiyar,et al.  Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. , 2008, Toxicology and applied pharmacology.

[84]  K. Dietz,et al.  Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines. , 2007, International journal of oncology.

[85]  Y. Hsieh,et al.  Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. , 2006, Toxicology and applied pharmacology.

[86]  Tae Gwan Park,et al.  Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[87]  M. Hirai,et al.  Chitosan Induces Apoptosis via Caspase‐3 Activation in Bladder Tumor Cells , 2001, Japanese journal of cancer research : Gann.

[88]  C. Reutelingsperger,et al.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. , 1998, Cytometry.

[89]  T. Smith,et al.  J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. , 1991, Biochemistry.